BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18376144)

  • 1. MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors.
    Yacoub A; Hamed H; Emdad L; Dos Santos W; Gupta P; Broaddus WC; Ramakrishnan V; Sarkar D; Shah K; Curiel DT; Grant S; Fisher PB; Dent P
    Cancer Biol Ther; 2008 Jun; 7(6):917-33. PubMed ID: 18376144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
    Yacoub A; Mitchell C; Hong Y; Gopalkrishnan RV; Su ZZ; Gupta P; Sauane M; Lebedeva IV; Curiel DT; Mahasreshti PJ; Rosenfeld MR; Broaddus WC; James CD; Grant S; Fisher PB; Dent P
    Cancer Biol Ther; 2004 Aug; 3(8):739-51. PubMed ID: 15197348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo.
    Yacoub A; Mitchell C; Lister A; Lebedeva IV; Sarkar D; Su ZZ; Sigmon C; McKinstry R; Ramakrishnan V; Qiao L; Broaddus WC; Gopalkrishnan RV; Grant S; Fisher PB; Dent P
    Clin Cancer Res; 2003 Aug; 9(9):3272-81. PubMed ID: 12960112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling.
    Yacoub A; Mitchell C; Lebedeva IV; Sarkar D; Su ZZ; McKinstry R; Gopalkrishnan RV; Grant S; Fisher PB; Dent P
    Cancer Biol Ther; 2003; 2(4):347-53. PubMed ID: 14508103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.
    Hamed HA; Yacoub A; Park MA; Archer K; Das SK; Sarkar D; Grant S; Fisher PB; Dent P
    Mol Pharmacol; 2013 Aug; 84(2):171-81. PubMed ID: 23661648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling.
    Yacoub A; Gupta P; Park MA; Rhamani M; Hamed H; Hanna D; Zhang G; Sarkar D; Lebedeva IV; Emdad L; Koumenis C; Curiel DT; Grant S; Fisher PB; Dent P
    Mol Cancer Ther; 2008 Feb; 7(2):314-29. PubMed ID: 18281516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins.
    Hamed HA; Yacoub A; Park MA; Eulitt P; Sarkar D; Dimitrie IP; Chen CS; Grant S; Curiel DT; Fisher PB; Dent P
    Cancer Biol Ther; 2010 Apr; 9(7):526-36. PubMed ID: 20107314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma.
    Hamed HA; Yacoub A; Park MA; Eulitt PJ; Dash R; Sarkar D; Dmitriev IP; Lesniak MS; Shah K; Grant S; Curiel DT; Fisher PB; Dent P
    Mol Ther; 2010 Jun; 18(6):1130-42. PubMed ID: 20179672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
    Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
    J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells.
    Yacoub A; Park MA; Gupta P; Rahmani M; Zhang G; Hamed H; Hanna D; Sarkar D; Lebedeva IV; Emdad L; Sauane M; Vozhilla N; Spiegel S; Koumenis C; Graf M; Curiel DT; Grant S; Fisher PB; Dent P
    Mol Cancer Ther; 2008 Feb; 7(2):297-313. PubMed ID: 18281515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cells.
    Yacoub A; Liu R; Park MA; Hamed HA; Dash R; Schramm DN; Sarkar D; Dimitriev IP; Bell JK; Grant S; Farrell NP; Curiel DT; Fisher PB; Dent P
    Mol Pharmacol; 2010 Feb; 77(2):298-310. PubMed ID: 19910452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.
    Nishikawa T; Ramesh R; Munshi A; Chada S; Meyn RE
    Mol Ther; 2004 Jun; 9(6):818-28. PubMed ID: 15194048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model.
    Kawakami K; Kawakami M; Kioi M; Husain SR; Puri RK
    J Neurosurg; 2004 Dec; 101(6):1004-11. PubMed ID: 15597761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma.
    Leath CA; Kataram M; Bhagavatula P; Gopalkrishnan RV; Dent P; Fisher PB; Pereboev A; Carey D; Lebedeva IV; Haisma HJ; Alvarez RD; Curiel DT; Mahasreshti PJ
    Gynecol Oncol; 2004 Aug; 94(2):352-62. PubMed ID: 15297172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic nanoparticles enhance the response of glioblastomas to radiation.
    Wu W; Klockow JL; Mohanty S; Ku KS; Aghighi M; Melemenidis S; Chen Z; Li K; Morais GR; Zhao N; Schlegel J; Graves EE; Rao J; Loadman PM; Falconer RA; Mukherjee S; Chin FT; Daldrup-Link HE
    Nanotheranostics; 2019; 3(4):299-310. PubMed ID: 31723547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner.
    Su ZZ; Lebedeva IV; Sarkar D; Gopalkrishnan RV; Sauane M; Sigmon C; Yacoub A; Valerie K; Dent P; Fisher PB
    Oncogene; 2003 Feb; 22(8):1164-80. PubMed ID: 12606943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
    Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
    Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.